enters susceptible liver cells — known as hepatocytes — and begins replicating. Inside the hepatocytes, HBV produces a surplus of viral antigens, including hepatitis B e antigen (HBeAg ...

New research has illustrated how hepatitis A virus uses cellular proteins, like PDAP1, to infect liver cells, replicate and ...

Viruses have thrived in humans for tens of thousands of years, evolving to take advantage of the machinery of cells to ...

Hepatitis E viruses (HEV) typically cause liver infections ... A research team has now developed a cell model to study the interaction of the virus with nerve cells. Using this model, the ...

All patients were ... July 10, 2024 — In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. Researchers have discovered ...

It is a leading cause of liver cancer, responsible for ... 2 SCG101 is designed to target a specific HBV peptide presented on infected cells, as well as hepatocytes with HBV DNA integration.

Our findings indicate that the neurological effects of HEV may be due - at least in part - to a direct infection of the nerve ...

SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data ...

Researchers have unveiled a groundbreaking advancement in liver failure care: the CATCH-LIFE-MELD score (Chinese ...